Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02754362
Title A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
NYU Perlmutter Cancer Center New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field